Clinical Trial Update: Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing the safety and biological activity of IP IMNN-001 (GEN-1) with neoadjuvant chemotherapy in epithelial ovarian cancer and related gynec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Cancer

Drugs mentioned

• IMNN-001 (GEN-1)

Snippet

Sponsor: Imunon | Conditions: Epithelial Ovarian Cancer, Fallopian Tube Cancer | Phase 1 | Status: COMPLETED